Why timing is critical for RhoGAM efficacy

RhoGAM works by neutralizing Rh-positive fetal red blood cells that enter the maternal circulation before the mother develops anti-D antibodies.1 This preventive approach depends on administering RhoGAM within the recommended window before potential exposure to Rh-positive fetal red blood cells.2 Therefore, knowing when to give RhoGAM is just as important as knowing how to administer it.

Antenatal administration

For unsensitized Rh-negative mothers, routine antenatal prophylaxis is a cornerstone of modern obstetrical practice. If the father or the baby is not conclusively shown to be Rh-negative, RhoGAM should be given to an Rh-negative mother in the following clinical situations to prevent Rh sensitization3:

  • At 26 to 28 weeks of pregnancy
  • Within 72 hours of delivery of an Rh-positive baby

This administration timing helps maintain passive anti-D coverage when there is an increased likelihood of small, often asymptomatic, fetomaternal hemorrhages during the third trimester.3,4

The importance of half-life

A longer half-life provides a greater residual anti-D in circulation over time.5 With a half-life of 30.9 days, >12.5% (>37.5 µg) of anti-D from a dose of RhoGAM could still remain in circulation at week 40.1,3*

This ensures mothers are protected through delivery, when risk of sensitization is highest.1,3,5,6

*No data, based on internal calculations. No head-to-head studies have compared the half-life or efficacy of all available anti-Ds.

Postpartum administration

If the newborn is Rh-positive, an additional 300 µg (1500 IU) dose of RhoGAM should be administered to the Rh-negative mother within 72 hours of delivery.3

This helps suppress the maternal immune response to Rh-positive fetal red blood cells that may have entered the maternal circulation during labor and delivery.3,7

Additional clinical indications

Beyond routine administration, RhoGAM is also crucial following specific events that carry a risk of fetomaternal hemorrhage, regardless of the gestational age.

RhoGAM should be administered under the following circumstances3:

  • Maternal or fetal bleeding during pregnancy from certain conditions
  • Actual or threatened pregnancy loss at any stage
  • Ectopic pregnancy
  • Amniocentesis
  • Chorionic villus sampling (CVS)
  • Manipulative procedures
  • Other obstetrical trauma

In these situations, dosing may vary depending on the estimated volume of fetomaternal hemorrhage.7 For more details, please see the full Prescribing Information.

Understanding when RhoGAM should be administered is essential for preventing Rh sensitization.3,7 By following established antenatal and postpartum prophylaxis guidelines and responding appropriately to sensitizing events, healthcare professionals can help ensure timely protection for Rh-negative mothers and support healthier pregnancy outcomes.

View the RhoGAM Administration Guide for detailed dosing and administration recommendations.